Anzeige
Mehr »
Dienstag, 30.09.2025 - Börsentäglich über 12.000 News
Seltene Ausgangslage: Unbekannter Kupfer-Explorer mit spekulativem Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EWWY | ISIN: US92859E2072 | Ticker-Symbol:
NASDAQ
29.09.25 | 22:00
3,130 US-Dollar
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
VIVOS THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
VIVOS THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur VIVOS THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17.09.Vivos Therapeutics, Inc: Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment110LITTLETON, Colo., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ: VVOS), a leading medical device and technology company specializing in the development...
► Artikel lesen
12.09.Vivos Therapeutics, Inc. - 8-K, Current Report1
20.08.Vivos Therapeutics, Inc. - 8-K, Current Report2
VIVOS THERAPEUTICS Aktie jetzt für 0€ handeln
20.08.Vivos Therapeutics GAAP EPS of -$0.55, revenue of $3.82M3
19.08.Vivos Therapeutics, Inc: Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update196Quarter highlighted by the key acquisition of The Sleep Center of Nevada, which is generating revenue and seeing strong patient demand for Vivos' differentiated array of highly effective OSA treatments...
► Artikel lesen
19.08.Vivos Therapeutics, Inc. - 10-Q, Quarterly Report2
30.07.Vivos Therapeutics appoints two executives to support growth strategy3
30.07.Vivos Therapeutics, Inc: Vivos Therapeutics Adds to Management Team to Support Expansion and Growth1
01.07.Vivos Therapeutics stock soars after Medicare approves VidaSleep oral appliance1
01.07.Vivos Therapeutics, Inc: Vivos Therapeutics Receives Medicare Approval for VidaSleep Oral Appliance1
26.06.Vivos Therapeutics Stock Climbs 9% On Positive Pediatric Sleep Apnea Study-
26.06.Vivos Therapeutics, Inc: New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children1
11.06.Vivos Therapeutics Finalizes Acquisition Of The Sleep Center Of Nevada1
11.06.Vivos Therapeutics, Inc: Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada281Transaction brings OSA diagnostic revenue to Vivos, plus Vivos' highly effective OSA treatment options to thousands of potential patients in the greater Las Vegas area Transaction also completes...
► Artikel lesen
06.06.Vivos Therapeutics ernennt Baker Tilly nach Fusion zum neuen Wirtschaftsprüfer1
06.06.Vivos Therapeutics, Inc. - 8-K, Current Report2
23.05.Vivos Therapeutics, Inc. - 8-K, Current Report1
16.05.Vivos Therapeutics GAAP EPS of -$0.45 misses by $0.10, revenue of $3.02M misses by $1.18M11
16.05.Vivos Therapeutics signals transformative growth with SCN acquisition and expects positive cash flow by end of 20251
15.05.Vivos Therapeutics, Inc. - 8-K, Current Report2
Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1